BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1376515)

  • 1. Cytoimmunologic monitoring of small bowel allograft recipients.
    Graeb C; Stangl MJ; Mebert H; Fischer T; Hammer C
    Transplant Proc; 1992 Jun; 24(3):1153-4. PubMed ID: 1376515
    [No Abstract]   [Full Text] [Related]  

  • 2. Indefinite small bowel allograft survival after limited immunosuppressive therapy is not due to specific hyporesponsiveness.
    Langrehr JM; Hoffman RA; Müller AR; Lee KK; Demetris AJ; Schraut WH
    Transplant Proc; 1991 Dec; 23(6):3248-50. PubMed ID: 1721425
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of donor irradiation to prolong allograft survival in small bowel transplantation in rats.
    Lee TK; Langrehr JM; Moynihan HL; Stangl MJ; Lee KK; Schraut WH
    Transplant Proc; 1992 Jun; 24(3):1183-4. PubMed ID: 1604579
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of experimental small bowel transplantation rejection with cyclosporine A.
    Liu Q; Yang R; Grosfeld JL; Collins MH; Pescovitz MD
    Transplant Proc; 1996 Oct; 28(5):2508-9. PubMed ID: 8907925
    [No Abstract]   [Full Text] [Related]  

  • 5. Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation.
    de Bruin RW; HogenEsch H; Heineman E; Jeekel J; Marquet RL
    Transplant Proc; 1991 Dec; 23(6):3257-9. PubMed ID: 1721429
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring of small bowel allograft rejection: comparison of intraluminal washout cytology and standard histology.
    Fischer T; Gräb C; Mebert H; Weiss M; Hammer C; Stangl MJ
    Transplant Proc; 1994 Jun; 26(3):1540. PubMed ID: 8030027
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of allograft rejection in rat small bowel transplantation by analysing the in situ distribution of S-phase lymphocytes.
    Okamoto M; Arakawa K; Akami T; Akioka T; Nakai I; Mitsuo M; Oka T; Fushiki S
    Transplant Proc; 1994 Jun; 26(3):1556. PubMed ID: 7518145
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of spleen transplantation and cyclosporine A treatment to ameliorate survival after small bowel transplantation.
    Pirenne J; D'Silva M; Jacquet N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1206. PubMed ID: 8442087
    [No Abstract]   [Full Text] [Related]  

  • 9. Small bowel transplantation in the rat: the effect of donor-specific transfusion 24 hours pretransplant and cyclosporine.
    Fecteau A; Tchervenkov J; Guttman FM; Rosenmann E
    Transplant Proc; 1992 Jun; 24(3):1166. PubMed ID: 1604571
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of lymphoid tissue for survival of small bowel allografts.
    Pirenne J; Williams JG; Kim S; Fryer J; Benedetti E; Hakim NS; Médot M; Najarian JS; Gruessner RW; Dunn DL
    Transplant Proc; 1995 Feb; 27(1):1359-60. PubMed ID: 7878911
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of short-term immunosuppressive therapy with FK 506 or CyA on the donor in small intestine allotransplantation in rats.
    Santiago SF; Fukuzawa M; Azuma T; Okada A
    Transplant Proc; 1992 Jun; 24(3):1189. PubMed ID: 1376520
    [No Abstract]   [Full Text] [Related]  

  • 12. Alterations in intestinal flora following small bowel transplantation.
    Browne BJ; Johnson CP; Edmiston CE; Hlava MA; Moore G; Roza AM; Telford GL; Adams MB
    Transplant Proc; 1992 Jun; 24(3):1102. PubMed ID: 1604535
    [No Abstract]   [Full Text] [Related]  

  • 13. The interaction of gamma irradiation of the allograft and recipient administration of cyclosporine in rat small bowel transplantation.
    Foster PF; Sankary HN; Kociss K; Xiao F; Williams JW
    Transplant Proc; 1992 Jun; 24(3):1175-6. PubMed ID: 1604576
    [No Abstract]   [Full Text] [Related]  

  • 14. Lethal graft-vs-host disease after cyclosporine therapy in recipients of sensitized small bowel allografts.
    Langrehr JM; Markus PM; Lee TK; Müller AR; Banner B; Lee KK; Schraut WH
    Transplant Proc; 1992 Jun; 24(3):1138. PubMed ID: 1604556
    [No Abstract]   [Full Text] [Related]  

  • 15. Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506.
    Takara T; Tchervenkov JI; Guttman FM; Fecteau A; Rosenmann E
    Transplant Proc; 1994 Jun; 26(3):1622. PubMed ID: 7518150
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-VLA-4 and cyclosporine synergistically prolong rat heterotopic small bowel allografts.
    Tice DG; Bruch D; Ikramuddin S
    Transplant Proc; 1996 Oct; 28(5):2496. PubMed ID: 8907920
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral leflunomide prevents small bowel allograft rejection in the rat.
    He G; McAlister VC; Lee TD; Bitter-Suermann H; Theal M; Wright J; MacDonald AS
    Transplant Proc; 1994 Jun; 26(3):1613. PubMed ID: 8030057
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of FK 506 on the survival of rat small bowel allografts.
    Takeda Y; Okajima K; Iga C; Date K; Ryo T; Niki M; Asaka K; Tezuka K; Isozaki H
    Transplant Proc; 1991 Dec; 23(6):3251. PubMed ID: 1721426
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats.
    Sawada H; Kaihara S; Egawa H; Inomata Y; Tanaka K; Yamaoka Y
    Transplant Proc; 1996 Oct; 28(5):2512-3. PubMed ID: 8907928
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental study of combined treatment with tacrolimus and donor splenocytes via the portal vein in small bowel transplantation.
    Miyauchi T; Ishikawa M; Tashiro S; Hisaeda H; Himeno K
    J Med Invest; 2001 Aug; 48(3-4):157-65. PubMed ID: 11694955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.